SCHEMBL5207987

SCHEMBL5207987

Cc1ccc(S(=O)(=O)NC(=O)C2CCC(c3nc(-c4cccc(C(F)(F)F)c4)c[nH]3)CC2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.44
KDM1A O60341 4/20 0.40
MAOA P21397 4/20 0.40
MAOB P27338 4/20 0.40
DHODH Q02127 1/20 0.39
JAK2 O60674 1/20 0.38
GRIN1 Q05586 1/20 0.37
GRIN2B Q13224 1/20 0.37
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CG P48736 1/20 0.36
EPHX2 P34913 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SLC5A1 P13866 1/20 0.36
AURKA O14965 2/20 0.35
ABL1 P00519 2/20 0.35
LCK P06239 1/20 0.35
IGF1R P08069 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202968 0.88 KCNH2 (0.44) KCNH2L3MBTL1KDM1AMAOAMAOB
SCHEMBL5208474 0.88 KCNH2 (0.44) KCNH2L3MBTL1KDM1AMAOAMAOB
SCHEMBL5207878 0.84 KCNH2 (0.46) KCNH2KDM1AMAOAMAOBJAK2
SCHEMBL5203621 0.82 KCNH2 (0.44) KCNH2KDM1AMAOAMAOBJAK2
SCHEMBL5202747 0.82 KCNH2 (0.44) KCNH2KDM1AMAOAMAOBJAK2
SCHEMBL5203000 0.77 KCNH2 (0.46) KCNH2KDM1AMAOAMAOBJAK2
SCHEMBL5202992 0.77 KCNH2 (0.46) KCNH2KDM1AMAOAMAOBJAK2
SCHEMBL5205158 0.77 KCNH2 (0.47) KCNH2KDM1AMAOAMAOBJAK2
SCHEMBL14608992 0.77 KCNH2 (0.47) KCNH2KDM1AMAOAMAOBJAK2
SCHEMBL5206565 0.77 KCNH2 (0.47) KCNH2KDM1AMAOAMAOBJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1306085-B1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor NEUROGEN CORP (US) 2007-02-14 EP claimed
US-7034034-B2 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives NEUROGEN CORPORATION (US) 2006-04-25 US disclosed
US-20030144290-A1 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives NEUROGEN CORPORATION 2003-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144290-A1 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives NPY5R, NPY4R, NPY1R KCNH2 1937/4885L3MBTL1 3132/4885KDM1A 783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.